Last reviewed · How we verify
NCT01963065
NICU-HEALTH (Hospital Exposures and Long-Term Health)
trial in Preterm Birth in 239 participants. Completed in 28 April 2020.
28 April 2020
Quick facts
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 239 |
| Start date | 1 March 2015 |
| Primary completion | 28 April 2020 |
| Estimated completion | 28 April 2020 |
| Sites | 1 location across United States |
Conditions studied
- Preterm Birth — all drugs for Preterm Birth →
Sponsor
Icahn School of Medicine at Mount Sinai
Who can join
Under 1, any sex, with Preterm Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the impact of environmental exposures during the NICU hospitalization on preterm infant development. The research team is interested in both chemical and non-chemical exposures. Research studies have shown that babies are exposed to plasticizers (bisphenol A, phthalates) in the NICU. Plasticizers are chemicals that are used to make plastic medical equipment soft and flexible. The research team wants to find out whether NICU-based exposure to chemicals (including common plasticizers) and other non-chemical exposures like stress makes a difference to how they grow and develop.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance.
Stroustrup A, Bragg JB, Andra SS, Curtin PC, et al · · 2018 · cited 44× · PMID 29505594 · DOI 10.1371/journal.pone.0193835 -
Sources of clinically significant neonatal intensive care unit phthalate exposure.
Stroustrup A, Bragg JB, Busgang SA, Andra SS, et al · · 2020 · cited 39× · PMID 30242269 · DOI 10.1038/s41370-018-0069-2 -
Application of growth modeling to assess the impact of hospital-based phthalate exposure on preterm infant growth parameters during the neonatal intensive care unit hospitalization.
Busgang SA, Spear EA, Andra SS, Narasimhan S, et al · · 2022 · cited 32× · PMID 35944631 · DOI 10.1016/j.scitotenv.2022.157830 -
Clinical validation of the Neonatal Infant Stressor Scale with preterm infant salivary cortisol.
Pourkaviani S, Zhang X, Spear EA, D'Agostino M, et al · · 2020 · cited 26× · PMID 31847006 · DOI 10.1038/s41390-019-0713-0 -
NICU-based stress response and preterm infant neurobehavior: exploring the critical windows for exposure.
Zhang X, Spear E, Hsu HL, Gennings C, et al · · 2022 · cited 23× · PMID 35173301 · DOI 10.1038/s41390-022-01983-3 -
The association of prenatal exposure to intensive traffic with early preterm infant neurobehavioral development as reflected by the NICU Network Neurobehavioral Scale (NNNS).
Zhang X, Spear E, Gennings C, Curtin PC, et al · · 2020 · cited 18× · PMID 32311904 · DOI 10.1016/j.envres.2020.109204 -
Cohort profile: the Neonatal Intensive Care Unit Hospital Exposures and Long-Term Health (NICU-HEALTH) cohort, a prospective preterm birth cohort in New York City.
Stroustrup A, Bragg JB, Spear EA, Aguiar A, et al · · 2019 · cited 13× · PMID 31772104 · DOI 10.1136/bmjopen-2019-032758 -
Environmental influences on child health outcomes: cohorts of individuals born very preterm.
O'Shea TM, McGrath M, Aschner JL, Lester B, et al · · 2023 · cited 9× · PMID 35948605 · DOI 10.1038/s41390-022-02230-5
Verify or expand the search:
- PubMed search for NCT01963065
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Birth
Currently open trials in the same condition.
- NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
- NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
- NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
- NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
- NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting
Other Icahn School of Medicine at Mount Sinai trials
Trials by the same sponsor.
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
- NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils · not yet recruiting
- NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction · NA · not yet recruiting
- NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation · NA · not yet recruiting
- NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01963065 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
- Last refreshed: 1 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01963065.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing